EntreMed (ENMD) | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
EntreMed (ENMD)

An SI Board Since January 1997

Posts	SubjectMarks	Bans	Symbol
2135	59	0	ENMD

Emcee: Mark Wise	Type: Unmoderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
410	If I had metastatic melanoma, I wouldn't care about a viral hepatitis. You	StockDoc	-	4/28/1998
409	I talked to gene therapy experts. They are not too optimistic, especially short	poodle	-	4/27/1998
408	You write: >Does ENMD have patent rights on any and all derivatives of endos	StockDoc	-	4/27/1998
407	Anyone know what is the latest on the thalidomide brain tumor trials? When can	muddphudd	-	4/26/1998
406	Sounds like the kind of information that will help someone, hopefully EntreMed,	muddphudd	-	4/26/1998
405	Bristol Meyers has the license from ENMD on Angiostatin. Not Smith Kline. For	John Bloxom	-	4/26/1998
404	The potential mechanism of action of endostatin; for those interested. EMBO J	StockDoc	-	4/25/1998
403	While this J&J thing sound like a rumor, I doubt ENMD considers selling end	StockDoc	-	4/25/1998
402	Wow alot to digest Mud! I will ponder it. Makes sense though that it isn'	Graham Dellaire	-	4/24/1998
401	Ferrara is a very good scientist, working with Genentech and on vascular endoth	StockDoc	-	4/24/1998
400	To any who are interested....I pulled the following from a post on the Yahoo En	muddphudd	-	4/24/1998
399	Graham & associates: Informative interchange; thanks. Ciao, Ted	Cage Rattler	-	4/20/1998
398	Graham, As far as I could understand, you worried that another company syntez.	poodle	-	4/20/1998
397	poodle good post.. nice to hear all points. I wanted to add a little bit. I w	Graham Dellaire	-	4/19/1998
396	Hi, Graham << Is there cross-licensing of endostatin through Harvard	poodle	-	4/19/1998
395	Very good discussion. ANY therapy that significantly prolongs survival WILL BE	StockDoc	-	4/19/1998
394	Hey mud, I agree too on you point about gene therapy. It doesn't matter h	Graham Dellaire	-	4/19/1998
393	Going to play devils advocate. Don't you think maybe ENMD might have made	Graham Dellaire	-	4/19/1998
392	An excellent post, Tom. Thanks for taking the time to share your understanding	John Bloxom	-	4/19/1998
391	I agree 100% with the issues you brought up. There are still too many inherent	muddphudd	-	4/19/1998
390	Tom, Thanks for your extremely helpful response. I am a neophyte in the realm	Michael Greene	-	4/18/1998
389	The posters on this board seem unusually knowledgeable and, unlike most boards,	Richard Haugland	-	4/18/1998
388	Michael, Although the Genetix approach sounds interesting...to the point that	Tom Caruthers	-	4/18/1998
387	Graham, As long as it's for development purposes they can clearly use endo	Biomaven	-	4/18/1998
386	Is there cross-licensing of endostatin through Harvard? How else can Genetix u	Graham Dellaire	-	4/17/1998

Go to reply# or date (mm/dd/yy):